GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease.

GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2018 11; 155(5):1463-1473.e6.

View in: PubMed

subject areas

Acetyl-CoA Carboxylase
Biomarkers
Carnitine
Double-Blind Method
Elasticity Imaging Techniques
Fatty Liver
Female
Humans
Isobutyrates
Liver Cirrhosis
Magnetic Resonance Imaging
Male
Middle Aged
Non-alcoholic Fatty Liver Disease
Oxazoles
Pyrimidines